BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6183027)

  • 1. Radioimmunoassay for prostatic acid phosphatase helps discriminate patients with prostatic cancer.
    Blick KE; Dick TT; Webb TA
    Clin Chem; 1982 Dec; 28(12):2373-7. PubMed ID: 6183027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for prostate-specific acid phosphatase in prostatic disease.
    Griffiths J; Rippe DF; Panfili PR
    Clin Chem; 1982 Jan; 28(1):183-6. PubMed ID: 7055908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study.
    Fair WR; Heston WD; Kadmon D; Crane DB; Catalona WJ; Ladenson JH; McDonald JM; Noll BW; Harvey G
    J Urol; 1982 Oct; 128(4):735-8. PubMed ID: 6183457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of serum prostatic acid phosphatase after prostatic massage.
    Pearson JC; Dombrovskis S; Dreyer J; Williams RD
    Urology; 1983 Jan; 21(1):37-41. PubMed ID: 6186064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of immunological assays for determining prostatic acid phosphatase.
    Romas NA; Shaw LM; Hsu KC; Ng PY; Pitts M; Tomashefsky P; Tannenbaum M
    Ann N Y Acad Sci; 1982; 390():104-9. PubMed ID: 6178342
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
    Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
    Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study.
    Morote Robles J; Ruibal Morell A; Palou Redorta J; de Torres Mateos JA; Soler Roselló A
    Eur Urol; 1988; 14(5):360-6. PubMed ID: 2458936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase.
    Foti AG; Cooper JF; Herschman H; Malvaez RR
    N Engl J Med; 1977 Dec; 297(25):1357-61. PubMed ID: 73133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase.
    Goldenberg SL; Silver HK; Sullivan LD; Morse MJ; Archibald EL
    Cancer; 1982 Nov; 50(9):1847-51. PubMed ID: 7116309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostatic acid phosphatase, measured by radioimmunology--an advantage?].
    Huber PR; Scholer A; Rist M; Eppenberger U; Ritishauser G
    Ther Umsch; 1982 Apr; 39(4):296-300. PubMed ID: 6179181
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostatic acid phosphatase by radioimmunoassay. Sensitivity compared with enzymatic assay.
    Lindholm GR; Stirton S; Liedtke RJ; Batjer JD
    JAMA; 1980 Nov; 244(18):2071-3. PubMed ID: 6159488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of serum prostatic acid phosphatase levels after prostatic massage.
    Wadström J; Huber P; Rutishauser G
    Urology; 1984 Dec; 24(6):550-1. PubMed ID: 6209846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of prostatic acid phosphatase in serum and bone marrow: radioimmunoassay and enzymic measurement compared.
    Huber PR; Scholer A; Linder E; Hagmaier V; Vogt H; Christen P; Eppenberger U; Rutishauser G
    Clin Chem; 1982 Oct; 28(10):2044-50. PubMed ID: 7127733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of acid phosphatase measurement in management of prostate cancer.
    Klein LA; Shapiro P
    Urology; 1981 Jun; 17(6):550-3. PubMed ID: 6166112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia.
    Fleischmann J; Catalona WJ; Fair WR; Heston WD; Menon M
    J Urol; 1983 Feb; 129(2):312-4. PubMed ID: 6187945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian variation of different fractions of serum acid phosphatase.
    Schmeller NT; Bauer HW
    Prostate; 1983; 4(4):391-5. PubMed ID: 6191317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and bone marrow radioimmunoassay of acid phosphatase in prostatic cancer.
    Sarosdy MF; Kledzik G; Lamm DL
    Urology; 1982 Jan; 19(1):33-6. PubMed ID: 6173949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma of the prostate: current thoughts on diagnosis and staging.
    Fair WR
    Surg Clin North Am; 1982 Dec; 62(6):1085-99. PubMed ID: 6184787
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between serum values of prostatic acid phosphatase and morphometric analysis in the cytologic diagnosis of prostatic carcinoma.
    Clar-Blanch F; Morell-Quadreny L; Fenollosa-Entrena B; Chuan-Nuez P; Gil-Salom M; Carretero-Gonzalez P; Llombart-Bosch A
    Eur Urol; 1992; 21 Suppl 1():75-8. PubMed ID: 1385135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The appropriate uses of prostatic acid phosphatase determination in the diagnosis of adenocarcinoma of the prostate.
    Griffiths J
    Ann N Y Acad Sci; 1982; 390():100-3. PubMed ID: 6953922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.